Alpha Tau Medical (DRTSW) Cash from Operations (2021 - 2022)

Alpha Tau Medical (DRTSW) posted Cash from Operations of 8743000.0 for Q2 2022, down 32.77% sequentially from 6585000.0 in Q1 2022.

Alpha Tau Medical (DRTSW) Cash from Operations (2021 - 2022) Analysis & Trends

Alpha Tau Medical has reported Cash from Operations for 2 years, with the latest figure at 8743000.0 in Q2 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cash from Ops. (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	1.13 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	813.00 Mn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-526.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	462.82 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	326.72 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	360.27 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-88.83 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	728.46 Mn
10	Alpha Tau Medical	383.00 Mn	200.58 Mn	-	-

Download Data